{"id":"https://openalex.org/W2188500367","doi":null,"title":"Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated y-site administration.","display_name":"Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated y-site administration.","publication_year":2008,"publication_date":"2008-07-01","ids":{"openalex":"https://openalex.org/W2188500367","mag":"2188500367","pmid":"https://pubmed.ncbi.nlm.nih.gov/23969774"},"language":"en","primary_location":{"id":"pmid:23969774","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23969774","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of pharmaceutical compounding","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056349034","display_name":"Michel Ben","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michel Ben","raw_affiliation_strings":["Analytical Research Laboratories, Oklahoma City, Oklahoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analytical Research Laboratories, Oklahoma City, Oklahoma","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019928561","display_name":"Craig Trusley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Craig Trusley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051758413","display_name":"Thomas C Kupiec","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas C Kupiec","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5010911099","display_name":"Lawrence A. Trissel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lawrence A Trissel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0093,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.76159502,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":"4","first_page":"368","last_page":"71"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.7285000085830688,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.7285000085830688,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14189","display_name":"Intravenous Infusion Technology and Safety","score":0.23229999840259552,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glycopyrrolate","display_name":"glycopyrrolate","score":0.9900000095367432},{"id":"https://openalex.org/keywords/neostigmine-methylsulfate","display_name":"neostigmine methylsulfate","score":0.9959999918937683},{"id":"https://openalex.org/keywords/drug-compatibility","display_name":"drug compatibility","score":0.8299999833106995},{"id":"https://openalex.org/keywords/drug-stability","display_name":"drug stability","score":0.7329999804496765},{"id":"https://openalex.org/keywords/y-site-administration","display_name":"Y-site administration","score":0.8600000143051147},{"id":"https://openalex.org/keywords/drug-admixtures","display_name":"drug admixtures","score":0.5379999876022339}],"concepts":[{"id":"https://openalex.org/C2909581452","wikidata":"https://www.wikidata.org/wiki/Q27162963","display_name":"Glycopyrrolate","level":3,"score":0.9341778755187988},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8141923546791077},{"id":"https://openalex.org/C2777411258","wikidata":"https://www.wikidata.org/wiki/Q410546","display_name":"Neostigmine","level":2,"score":0.7604500651359558},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5842535495758057},{"id":"https://openalex.org/C186399102","wikidata":"https://www.wikidata.org/wiki/Q903517","display_name":"Chemical stability","level":2,"score":0.5070998668670654},{"id":"https://openalex.org/C2776460385","wikidata":"https://www.wikidata.org/wiki/Q420060","display_name":"Hydrochloride","level":2,"score":0.430157870054245},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.2629375755786896},{"id":"https://openalex.org/C2775859210","wikidata":"https://www.wikidata.org/wiki/Q26272","display_name":"Atropine","level":2,"score":0.1674153208732605},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.14255112409591675},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.09366711974143982}],"mesh":[],"locations_count":2,"locations":[{"id":"pmid:23969774","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23969774","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of pharmaceutical compounding","raw_type":"Journal Article"},{"id":"mag:2188500367","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23969774","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W47336405","https://openalex.org/W61982422","https://openalex.org/W148804888","https://openalex.org/W1489739600","https://openalex.org/W1508478281","https://openalex.org/W1888693696","https://openalex.org/W1978116278","https://openalex.org/W2048601660","https://openalex.org/W2062484591","https://openalex.org/W2120978512","https://openalex.org/W2131833905","https://openalex.org/W2133116774","https://openalex.org/W2155726820","https://openalex.org/W2160359567","https://openalex.org/W2314772157","https://openalex.org/W2397203933"],"related_works":["https://openalex.org/W1536360637","https://openalex.org/W1489739600","https://openalex.org/W2005577242","https://openalex.org/W2062484591","https://openalex.org/W47336405","https://openalex.org/W148804888","https://openalex.org/W61982422","https://openalex.org/W2113212455","https://openalex.org/W2164477138","https://openalex.org/W2131833905"],"abstract_inverted_index":{"The":[0,128],"objective":[1],"of":[2,13,44,50,112],"this":[3],"study":[4],"was":[5,58,78,98,147],"to":[6],"evaluate":[7],"the":[8,110,169],"physical":[9],"and":[10,26,52,70,73,90,93,121,123,132,144,149,160,163,181,186],"chemical":[11],"stability":[12,57,77,97],"undiluted":[14,22],"palonosetron":[15,45,158],"hydrochloride":[16,46,159,177],"50":[17],"mcg/mL":[18],"when":[19,134],"mixed":[20],"with":[21,47,136,172,184],"glycopyrrolate":[23,51,162,185],"0.2":[24],"mg/mL":[25,30],"neostigmine":[27,53,164,187],"methylsulfate":[28,54,165,188],"0.5":[29],"during":[31,189],"simulated":[32,190],"Y-site":[33,191],"administration.":[34,192],"Duplicate":[35],"test":[36,171],"samples":[37,129],"were":[38,116,130],"prepared":[39],"by":[40,60,80,100],"admixing":[41],"7.5":[42,48],"mL":[43,49],"injections.":[55],"Physical":[56],"assessed":[59,79,99],"using":[61,81,101],"a":[62,82,137],"multi-step":[63,83],"evaluation":[64],"procedure":[65,85],"that":[66,86],"included":[67,87],"both":[68,88,161],"turbidimetric":[69,89],"particulate":[71,91,145],"measurements":[72,92],"visual":[74,94],"inspection.":[75,95],"Chemical":[76,96],"evalutation":[84],"stability-indicating":[102],"high-performance":[103],"liquid":[104,154],"chromatography":[105,155],"analytical":[106],"techniques":[107],"based":[108],"on":[109],"determination":[111],"drug":[113,174],"concentrations.":[114],"Evaluations":[115],"perfromed":[117],"initially":[118],"upon":[119],"mixing":[120],"1":[122],"4":[124],"hours":[125],"after":[126],"mixing.":[127],"clear":[131],"colorless":[133],"viewed":[135],"Tyndall":[138],"beam.":[139],"Measured":[140],"turbidity":[141],"remained":[142,166],"unchanged":[143],"content":[146],"low":[148],"exhibited":[150],"little":[151],"change.":[152],"High-performance":[153],"analysis":[156],"found":[157],"stable":[167,183],"throughout":[168],"4-hour":[170],"no":[173],"loss.":[175],"Palonosetron":[176],"is":[178],"physically":[179],"compatible":[180],"chemically":[182]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2016-06-24T00:00:00"}